Mindray promotes a meeting of medical minds at the 71st CMEF
CAL-8000, launched in November 2013 and on show at CMEF for the first time, typifies Mindray’s integrated approach. The exceptional performance of the CAL-8000 is achieved by combining fully automated instruments with a proven track record in clinical laboratory analysis (the BC-6800 haematology analyser and the SC-120 slide maker and stainer) in one powerful workstation.
Another product making its debut at CMEF was the M9 portable ultrasound system. The M9 demonstrates that sonographers no longer need to sacrifice performance for portability. Despite the easy mobility, the M9 boasts premium capability offering industry leading technologies such as Echo-Boost, LVO with Stress Echocardiograpy, TTQA, UWN with contrast imaging and natural touch elastography, making it an ideal shared-service solution for use within multiple clinical settings.
Portability also defines the new BeneView TDS (T1 docking system). This system can be used wirelessly with patients being transported in emergency vehicles, stays with the patient in the ER and can be transferred with the patient to theatre and/or the intensive care suite. The T1’s specifically designed handle makes it easily portable while the patient is on the move. The availability of a dockable handheld monitor in addition to a full size static screen means that the patient’s vital signs can be monitored ‘on the go’ as well as at the bedside. In addition, the TDS Docking Station can connect a 19'' touchscreen which provides the same intuitive BeneView user interface.
All three new products exemplify Mindray’s commitment to R&D and innovative product development. By involving the best minds and the most innovative institutions in its research, Mindray aims to produce more widely available, accessible and technologically advanced healthcare solutions. When interviewed at CMEF, Mindray Chief Administrative Officer Wang Jianxin explained: “We take a three-pronged approach to innovation in product development: proprietary research involving a high degree of cooperation with universities, research institutes, hospitals and clinics; recruitment of highly talented researchers from outside China; and a merger and acquisition strategy that not only enriches our product lines but also broadens our international marketing channels.”
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray Chairman's Statement on Efforts to Combat COVID-192020-04-05
Sii Forte Italia! From Mindray, with All Our Efforts to Support2020-04-03
Mindray Makes Donations to Designated Hospitals for COVID-19 in Wuhan2020-03-05
Mindray in Action to Combat COVID-192020-02-24
Mindray Showcases Latest Medical Innovations at Arab Health & Medlab Middle East 20202020-02-07